Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion

NCT02694198 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT02694198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02694198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
Lead sponsor
Ain Shams Maternity Hospital
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
March 31, 2016
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medical; abortion, fetus